Notice NOT-HL-20-798 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: Full Stack Software Engineer Location: Cambridge, Cambridgeshire, England

Competitive Salary: EMBL: Bioinformatics Developer Location: Cambridge, Cambridgeshire, England

Notice NOT-OD-20-142 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-ES-20-015 from the NIH Guide for Grants and Contracts. The intent of this FOA is to encourage applications to develop and conduct short-term research education activities with the goal of providing training to improve knowledge and skills needed to conduct environmental health research. Short courses submitted under this FOA are expected to include relevant intensive hands-on training in environmental health science topics. In addition to in-person instruction, courses that incorporate innovative or novel education models, such as project-based learning or virtual instruction, are encouraged.

Funding Opportunity PAR-20-271 from the NIH Guide for Grants and Contracts. The goal of this FOA is identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy or immunotherapy. The FOA is intended to support discovery research for the identification of validated hits relevant to health-related outcomes of participating NIH Institutes. Stages of discovery research covered by this FOA include: 1) assay development for specific biological targets and disease mechanisms relevant to the mission of participating NIH Institutes with the intent to screen for small molecule compounds that show potential as probes for use in advancing knowledge about the known targets, identifying new targets, or as pre-therapeutic leads; 2) screen implementation high throughput target-focused approaches or moderate throughput phenotypic- and fragment-based approaches to identify initial screening hits; 3) hit validation, including implementation of secondary assays that are orthogonal to the primary assay, advanced cheminformatics analysis and initial medicinal chemistry inspection to prioritize the hit set, and follow-up assays to characterize mode and mechanism of action of the validated hits; 4) hit-to-lead optimization, including SAR to optimize target engagement, selectivity and to minimize chemical liabilities, ADME, PK and PD studies, and, if appropriate, in vivo modeling to test efficacy or biological effects.

A competitive remuneration package will be offered to the successful candidate. : DHR International: The Chief Bioinformatics Officer will lead all bioinformatics analysis and data management of HKGI to facilitate clinical application and research. Hong Kong

A competitive remuneration package will be offered to the successful candidate.: DHR International: The Chief Scientific Officer will build all scientific strategies and work closely with stakeholders in developing clinical and ethical protocols. Hong Kong

Funding Opportunity PAR-20-267 from the NIH Guide for Grants and Contracts. NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing research and also to extend the focus of research to drug abuse and addiction. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are encouraged. An application should integrate and promote research in existing funded projects, to achieve new and creative directions. It is expected that individual core activities reflect a relationship to the integrating theme of the Center and the Center is expected to provide research opportunities and experiences to new investigators , and share findings, data and their resources, consistent with achieving the goals of the program.

Funding Opportunity PAR-20-269 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that apply a cross-disciplinary and team science approach to gain comprehensive mechanistic understanding of the impact of sex differences on the trajectories of brain aging, phenotypes, and risk of Alzheimer's Disease (AD) and AD-related dementia (ADRD), and on precision medicine for treatment and prevention of AD/ADRD, including the responsiveness to pharmacologic and non-pharmacologic interventions.

F. Hoffmann-La Roche AG: As a (Associate)/Group Director within our Personalized HealthCare function you will be responsible for the data science strategies, and lead a Switzerland (CH)

Funding Opportunity RFA-DA-21-006 from the NIH Guide for Grants and Contracts. The purpose of this FOA isto develop tools and technologies to conduct cientifically rigorous, ethical, efficient, and cost-effective research infrastructure that supports germline and somatic transgenic and gene editing studies in the common marmoset (Callithrix jacchus). These studies should to answer crucial scientific questions that require genetic perturbation in a non-human primate model organism with the aim of supporting BRAIN goals of understanding the brain in health an disease.

£32,235 - £35,709 per annum: Animal and Plant Health Agency: The Animal and Plant Health Agency (APHA) is an executive agency of the Department for Environment, Food & Rural Affairs..... New Haw, Addlestone

Notice NOT-MH-20-071 from the NIH Guide for Grants and Contracts

Notice NOT-AT-20-020 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-133 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-136 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-137 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-134 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-135 from the NIH Guide for Grants and Contracts